The lead variants at PNPLA3, TM6SF2, and APOE were either coding or in high LD with a coding variant and have all been previously implicated in the full spectrum of MASLD, including cirrhosis and HCC.8 This evidence concerns the gene TM6SF2 and hepatocellular carcinoma.